Entradas Etiquetadas :

core lab

QUIBIM at BIO 2017

QUIBIM in BIO 2017

Our company was present again this year in the incredibly huge BIO International Convention in San Diego, California, from June 19th to 22nd. Our registration included both a booth at the Spanish pavilion and the access to the One-to-One partnering meetings.

We had 15 planned meetings and many other new contacts thanks to the interaction at our exhibitor space with agents interested in QUIBIM business model. We made several demonstrations of QUIBIM Precision platform and image analysis capabilities in clinical trials. From all the contacts and meetings performed at BIO, I wanted to point out the classification we found according to their profile:

  • Scientific parks and incubators (30%)
  • Investors in Life Sciences (20%)
  • CRO’s and Pharma companies (50%)

From our experience last year in San Francisco, in this edition there has been a higher interest from scientific parks and incubators beyond Boston and Silicon Valley to attract companies to their facilities, showing the benefits of establishing the companies in specific locations, specially in the different states of US. The number of investors stayed similar, but we have been an increasing interest in the field of Medical Devices. Regarding CRO’s and Pharma companies, most of them are progressively considering medical imaging in their clinical trials, and the best, considering us for their solutions. We are so proud to cover those unmet needs on advanced image analysis services for Clinical Trials, allowing pharma companies, CRO’s and Principal Investigators to follow-up in real time their study. In fact, one of the main trends at BIO this year was how data processing will change the way new drugs are developed and launched into market.

QUIBIM CEO (Angel Alberich-Bayarri) & Booth at BIO 2017

QUIBIM CEO (Angel Alberich-Bayarri) & Booth at BIO 2017

 

We were so glad to have this exhibitor space at the Spanish pavilion, and compared to previous editions, it was also the first time that the Valencia region had a dedicated area inside it (similar to Biocat from Catalonia and Biobasque from Basque Country). The Valencia area was organised by IVACE (Instituto Valenciano para la Competitividad Empresarial), and the organism was represented by Mrs. Mónica Payá (representative for foreign investment of IVACE). The Principe Felipe Research Centre (CIPF), was also represented by Oscar David Sánchez (Projects and Technology Transfer Manager).

Valencia region representatives at BIO 2017 in San Diego, Angel Alberich (QUIBIM), Mónica Payá (IVACE), Daniel Calvo (BIOPOLIS), Marisol Quintero (Biooncotech)

Valencia region representatives at BIO 2017 in San Diego, Angel Alberich (QUIBIM), Mónica Payá (IVACE), Daniel Calvo (BIOPOLIS), Marisol Quintero (Biooncotech)

 

Valencia region representatives at BIO 2017 in San Diego, Óscar David Sánchez (CIPF), Mónica Payá (IVACE), Daniel Calvo (BIOPOLIS), Angel Alberich-Bayarri (QUIBIM)

Valencia region representatives at BIO 2017 in San Diego, Óscar David Sánchez (CIPF), Mónica Payá (IVACE), Daniel Calvo (BIOPOLIS), Angel Alberich-Bayarri (QUIBIM)

 

All the days at BIO were so productive that there is a significant work to be done at home, contacting back with the people we met and following up these new relationships.

Obviously not everything is work and there is also some spare time for entertainment at BIO, in the following picture, a rock band playing at the middle of Gaslamp quarter in San Diego. The streets were closed to welcome BIO 2017 participants in a nice evening with food, drink and music, a nice experience!

Band performing at BIO 2017 in middle of Gaslamp quarter

Band performing at BIO 2017 in middle of Gaslamp quarter

Our experience at BIO 2016 and USA tour

We were delighted to be present at past BIO conference in San Francisco (Moscone Center), from 6th to 9th of June, with a booth in the Spanish pavillion. Our presence was due to the incorporation of QUIBIM in the ICEX next program, the Spanish program that assists SME’s in their internationalization.

I can now confirm that the meeting covered my expectations and I agree with the definition in their website: The BIO International Convention (BIO) attracts over 15,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. This event covers a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.

QUIBIM stand at BIO convention in Spain Pavillion and its CEO, Angel Alberich-BayarriQUIBIM stand at BIO convention in Spain Pavillion and its CEO, Angel Alberich-Bayarri

The attendees were also variate:

  • One-third of BIO attendees come from outside the U.S.
  • 2,500+ CEO’s from leading biotech companies
  • More than 70% of attendees are either Managers, Directors, C-Level or Executive Management.
  • All company sizes: 33% of attendees are from companies with more than 500 employees and 40% are from companies with fewer than 50 employees.

Our first event in the congress was the session “Spain Kicks off 2016 BIO International Convention” in a charming venue: The Ferry Building. A session were we were able to learn from leading experts on how to select the appropriate path, develop and execute our strategy successfully, as well as best practices and what we need to understand in any approach. High level executives from TTS Global Initiative, Breakout Labs, CytomX, GeronIRB Barcelona, pH PharmaRoche, Stanford University and the Thiel Foundation participated in the panel.

In the BIO convention, we had a total of 23 one-to-one partnering meetings organised. The meetings were very well organised and distributed and having the possibility of discussing 30 minutes with potential customers, providers or investors to explore further ways of collaboration justifies our presence in the congress. New business opportunities that are now being executed arose.

After BIO convention, we decided to spend a pair of days at Case Western Reserve Medical Center in Cleveland, visiting Dr. Pablo Ros, member of our advisory board and Chairman at the Department of Radiology in UH Case Medical Center. The purpose of the visit was to discover the biomedical engineering department and the projects that are being performed. Among the short meetings I shared with senior reserchers, I must highlight the meeting with Dr. Mark Griswold, the promoter of the MRI fingerprinting technique.

In summary, we will probably repeat our attendance at BIO conference due to the success of networking.